Effectiveness & Safety of Collagen Membrane (FormaAid®) in the Treatment

Status Not yet recruiting

Clinical Trial Summary

The goal of this clinical trial is to evaluate clinically and radiographically effectiveness and products safety of the collagen membrane (FormaAid®) in the treatment of periodontal regeneration using guided tissue regeneration (GTR) performed by the trained periodontists. The main question it aims to answer are: - The difference of periodontal status: clinical attachment level (CAL), periodontal pocket depth (PPD), gingival recession (GR), gingival Index (GI) and plaque index (PI). - The difference of intrabony defect height. - The difference of gingival tissue thickness and gingival tissue volume. - The incidences of safety indicators. Participants will be randomized into either experiment group or control group, undergo guided tissue regeneration (GTR) surgery at week 1, and re-visited on week 3, 5, 13 and 27 after the GTR surgery. Researchers will compare if the test product is non-inferior to Bio-Gide.

Clinical Trial Description

This study is conducted as a randomized controlled clinical trial regarding the use of two different marketed collagen membrane with freeze-dried bone allograft (FDBA) in treatment of periodontal intrabony defects. Collagen membrane acts as a barrier that prevents soft tissue (gums) from growing into the area where bone regeneration is desired. This allows the bone and other necessary tissues to regenerate more effectively. Sutures are removed 14 days after the surgery. Patients are then followed up at 5, 13- and 27-weeks post-surgery for Gl, PI, GR, PPD, and CAL to evaluate the tissue condition. The cone beam computed tomography (CBCT) and the X-ray radiographic evaluation will be assess in this study twice before and after treatment week 27 on the investigational site. And all subjects will receive intra-oral scanning with an intra-oral scanner at baseline and week 5, 13, 27 follow-up visits to assess the gingival tissue thickness and gingival tissue volume change. Safety data and adverse events would be recorded throughout the study. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06252935
Study type	Interventional
Source	Maxigen Biotech Inc.
Contact	LiRong Chen
Phone	+88633287222
Email	lirong.chen@mbi.com.tw
Status	Not yet recruiting
Phase	N/A
Start date	March 12, 2024
Completion date	October 31, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04191200` - Oral Status of Patients Suffering From SCHIZophrenia Followed at Charles Perrens Hospital
Completed	`NCT02205619` - Amount of Cementum After Scaling, Root Planing and Glycine Air Polishing	Phase 2/Phase 3
Recruiting	`NCT05597956` - Effectiveness of Infiltration With Resin in Treatment of MIH Incisors in Children Showing Opacities	N/A
Not yet recruiting	`NCT06081868` - RCT on Effectiveness of Oral Health Preventive Programmes in School Children in Uganda	N/A
Recruiting	`NCT03851224` - Immediate Implant With no Graft , Autogenous Graft or Xenograft.	N/A
Completed	`NCT04005456` - Personalized Lifestyle Intervention for Improving Functional Health Outcomes Using N-of-1 Tent-Umbrella-Bucket Design	N/A
Completed	`NCT04153266` - Oral Epithelial Dysplasia Informational Needs Questionnaire
Enrolling by invitation	`NCT05157009` - Immediate Implant Outcomes With and Without Bone Augmentation	N/A
Completed	`NCT03729167` - Instrumentation Effectiveness of Modified, Area-Specific Hand Scalers During Non-Surgical Periodontal Therapy	N/A
Completed	`NCT04492306` - Clinical Evaluation of Dimethyl Sulfoxide Dentin Pre-treatment	N/A
Recruiting	`NCT04141215` - Allogeneic Bone Paste Versus Allogeneic Bone Powder	N/A
Recruiting	`NCT06182462` - Virtual Reality Distraction for Dental Anxiety (RCT)	N/A
Enrolling by invitation	`NCT04894201` - Deep Learning to Summarize Findings in Dental Panoramic Radiographs
Not yet recruiting	`NCT05371535` - A Clinical Trial to Evaluate the Safety and Effectiveness of MatrixOssTM Bone Graft	N/A
Enrolling by invitation	`NCT05022368` - Oral Device Clinical Trial	Phase 1
Not yet recruiting	`NCT03103685` - Continue vs. Stop P2Y12 Inhibitor on Bleeding in Patient Receiving DAPT Undergoing Dental Procedure.	Phase 4
Completed	`NCT05282212` - Point of Care, High Resolution and 3-Dimensional Ultrasonography
Completed	`NCT04686084` - Dual Energy Cone-Beam Computed Tomography (DE-CBCT) Assessment of Jaw Bone Density	N/A
Completed	`NCT04657757` - Investigation of Bacterial Adhesion and Bactericide Effect ex Vivo on Different Implant Restoration Materials	N/A
Recruiting	`NCT03819166` - Behavioral Support Techniques on Anxiety and Physical Reaction From Dental Treatment	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Effectiveness and Safety of Collagen Membrane (FormaAid®) in the Treatment of Periodontal Regeneration

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms